Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Novel trisaccharide based phospholipids as immunomodulators
Srinivasa Reddy Bonam
, Debabrata Bhunia
, Sylviane Muller
, Sridhar Goud Nerella
, Mallika Alvala
, Sampath Kumar Halmuthur Mahabalarao
Research output
:
Contribution to journal
›
Article
›
peer-review
13
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel trisaccharide based phospholipids as immunomodulators'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Phospholipids
100%
Immunomodulator
100%
Trisaccharide
100%
Phosphatidylinositol Mannosides
100%
Glycophospholipids
100%
Dendritic Cell-specific Intercellular Adhesion molecule-3 Grabbing Nonintegrin
66%
Phosphate
33%
Specific Antibodies
33%
Phosphorylation
33%
Receptor-ligand Interaction
33%
Specific Interactions
33%
Cytokine Expression
33%
Monocyte-derived Dendritic Cells (MoDCs)
33%
Ovalbumin
33%
IgG Titer
33%
Antibody IgG
33%
Integrin Expression
33%
Molecular Docking Studies
33%
Vaccine Preparation
33%
Immunomodulatory Properties
33%
Immunopotentiating Activity
33%
Immunomodulatory Activity
33%
Focused Library
33%
Docking Studies
33%
Adjuvant Properties
33%
Imidates
33%
Tailor-made
33%
Neuroscience
Phospholipid
100%
Immunomodulating Drugs
100%
Phosphatidylinositol
100%
Mannoside
100%
Trisaccharide
100%
Glycophospholipid
100%
In Vitro
66%
DC-SIGN
66%
In Vivo
33%
Ovalbumin
33%
Molecular Docking
33%
Receptor
33%
Cytokine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Immunomodulating Agent
100%
Phospholipid
100%
Phosphatidylinositol
100%
Mannoside
100%
Trisaccharide
100%
Glycophospholipid
100%
CD209 Antigen
66%
Adjuvant
33%
Receptor
33%
Cytokine
33%
Ovalbumin
33%
Diseases
33%
Immunology and Microbiology
Immunomodulating Drugs
100%
DC-SIGN
100%
In Vitro
100%
Cytokine
50%
Adjuvant
50%
Titer
50%
Dendritic Cell
50%
Immunopotentiation
50%
Molecular Docking
50%